Research
Read how they describe their research on their University of Alberta profile.
Latest papers
Ketone therapy prevents semaglutide-induced loss of cardiac mass.
European journal of preventive cardiology · 2026
1 publications.
Ketone therapy prevents semaglutide-induced loss of cardiac mass.
Schmidt MA, Abuetabh Y, Naganuma M, Vaka R, Zolondek MCP, Levasseur JL, Morales-Llamas DY, El-Ghiaty MA, Braun S, Sahid D, Khan L, Kwan EA, Roth DK, Ferdaoussi M, Fahlman RP, Dyck JRB
Frequent collaborators
- Jason Dyck and Mourad Ferdaoussi: 28 shared papers
- Jason Dyck and Richard Fahlman: 2 shared papers
- Jason Dyck and Ramana Vaka: 1 shared paper
- Richard Fahlman and Mourad Ferdaoussi: 1 shared paper
- Richard Fahlman and Ramana Vaka: 1 shared paper
- Mourad Ferdaoussi and Ramana Vaka: 1 shared paper
- Pharmacology Dept
- Pediatrics Dept
- Campus Saint-Jean - Campus Saint-Jean
- Biochemistry Dept
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.